You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Correction: Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma

Article metrics

Article menu

See original article:

Download PDFPDF

XML
Correction
Correction: Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma

 

Online download statistics by month:

Online download statistics by month: June 2020 to June 2025

AbstractFullPdf
Jun 20200425
Jul 20200277
Aug 20200154
Sep 20200295
Oct 20200165
Nov 2020021
Dec 2020040
Jan 20210114
Feb 2021072
Mar 2021063
Apr 2021041
May 2021031
Jun 20210102
Jul 2021074
Aug 2021043
Sep 2021089
Oct 20210513
Nov 20210815
Dec 20210111
Jan 2022090
Feb 2022042
Mar 2022063
Apr 20220161
May 20220209
Jun 20220203
Jul 20220102
Aug 20220102
Sep 202201113
Oct 20220233
Nov 20220710
Dec 2022021
Jan 2023053
Feb 20230241
Mar 2023073
Apr 2023001
May 2023036
Jun 2023021
Jul 2023045
Aug 2023025
Sep 2023050
Oct 2023052
Nov 2023073
Dec 2023080
Jan 20240112
Feb 2024088
Mar 20240244
Apr 2024046
May 2024082
Jun 2024042
Jul 20240124
Aug 2024043
Sep 2024095
Oct 2024088
Nov 20240162
Dec 2024075
Jan 2025074
Feb 2025063
Mar 2025032
Apr 20250194
May 2025062
Jun 20250103
Total0573273